1. Home
  2. VRME vs TENX Comparison

VRME vs TENX Comparison

Compare VRME & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$1.04

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$12.90

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
TENX
Founded
1999
1967
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
56.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VRME
TENX
Price
$1.04
$12.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$1.50
$22.50
AVG Volume (30 Days)
10.0M
237.0K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$4.63
52 Week High
$5.00
$14.22

Technical Indicators

Market Signals
Indicator
VRME
TENX
Relative Strength Index (RSI) 66.12 62.05
Support Level $0.59 $11.06
Resistance Level $1.41 $14.02
Average True Range (ATR) 0.09 1.19
MACD 0.05 -0.06
Stochastic Oscillator 54.82 55.06

Price Performance

Historical Comparison
VRME
TENX

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: